Serum Institute Gets Nod To Resume Oxford COVID-19 Vaccine Trial In India

Drugs Controller General of India (DCGI) Dr VG Somani on Tuesday gave permission to Serum Institute of India to resume clinical trial of the Oxford COVID-19 vaccine candidate in the country while...

source https://www.ndtv.com/india-news/serum-institute-gets-nod-to-resume-oxford-covid-19-vaccine-trial-in-india-2296002